Literature DB >> 23371456

Colon may provide new therapeutic targets for treatment of chronic kidney disease with Chinese medicine.

Chuan Zou1, Zhao-Yu Lu, Yu-Chi Wu, Li-Hong Yang, Guo-Bin Su, Xi-Na Jie, Xu-Sheng Liu.   

Abstract

Chronic kidney disease (CKD) has become a worldwide health and social problem. Retarding its progression to end-stage renal disease is beneficial both to the patients and the healthcare system. Plenty of clinical trials have indicated that enema with Chinese medicine could effectively prevent chronic renal failure, and was widely used in the clinical practice. However, studies on mechanism were still nearly blank, which may prevent further improvement of therapeutic efficacy. Recent studies had discovered that colon was an important organ where uremic toxins were generated. The uremic toxins involved could not only promote CKD progression, but also was closely correlated with CKD mortality. Reducing production and promoting excretion of toxins were confirmed to reduce renal tubule interstitial fibrosis and delay renal progression. On the basis of the theory of gut-kidney axis above, we had conducted pilot clinical researches to evaluate the effect of enema with Chinese medicine on the intestinal flora, gut barrier, enterogenous uremic toxins and renal protection. The preliminary results revealed that rheum enema through colon could accelerate intestinal dynamics, improve intestinal barrier function, regulate intestinal flora and reduce production and absorption of intestine-derived uremic toxins such as indoxyl sulfate, which may reduce renal fibrosis and delay renal progression. Further studies could provide more evidence for colon as a new therapeutic target for the treatment of CKD with Chinese medicine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23371456     DOI: 10.1007/s11655-013-1351-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  27 in total

1.  Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease.

Authors:  Natarajan Ranganathan; Pari Ranganathan; Eli A Friedman; Anthony Joseph; Barbara Delano; David S Goldfarb; Paul Tam; A Venketeshwer Rao; Emmanuel Anteyi; Carlos Guido Musso
Journal:  Adv Ther       Date:  2010-08-16       Impact factor: 3.845

2.  Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease.

Authors:  Sophie Liabeuf; Daniela V Barreto; Fellype C Barreto; Natalie Meert; Griet Glorieux; Eva Schepers; Mohammed Temmar; Gabriel Choukroun; Raymond Vanholder; Ziad A Massy
Journal:  Nephrol Dial Transplant       Date:  2009-11-13       Impact factor: 5.992

3.  Colonic contribution to uremic solutes.

Authors:  Pavel A Aronov; Frank J-G Luo; Natalie S Plummer; Zhe Quan; Susan Holmes; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

4.  Gut flora may offer new therapeutic targets for the traditional Chinese medicine enteric dialysis.

Authors:  Zhan-Jun Shu; Ying Cao; Upur Halmurat
Journal:  Expert Opin Ther Targets       Date:  2011-09-09       Impact factor: 6.902

5.  Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation.

Authors:  Zohra Tumur; Hidehisa Shimizu; Atsushi Enomoto; Hitoshi Miyazaki; Toshimitsu Niwa
Journal:  Am J Nephrol       Date:  2010-04-14       Impact factor: 3.754

6.  P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production.

Authors:  Eva Schepers; Natalie Meert; Griet Glorieux; Jan Goeman; Johan Van der Eycken; Raymond Vanholder
Journal:  Nephrol Dial Transplant       Date:  2006-10-13       Impact factor: 5.992

7.  Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

Authors:  Fellype C Barreto; Daniela V Barreto; Sophie Liabeuf; Natalie Meert; Griet Glorieux; Mohammed Temmar; Gabriel Choukroun; Raymond Vanholder; Ziad A Massy
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-20       Impact factor: 8.237

8.  Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial.

Authors:  Tadao Akizawa; Yasushi Asano; Satoshi Morita; Takafumi Wakita; Yoshihiro Onishi; Shunichi Fukuhara; Fumitake Gejyo; Seiichi Matsuo; Noriaki Yorioka; Kiyoshi Kurokawa
Journal:  Am J Kidney Dis       Date:  2009-07-17       Impact factor: 8.860

9.  p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

Authors:  I-Wen Wu; Kuang-Hung Hsu; Chin-Chan Lee; Chiao-Yin Sun; Heng-Jung Hsu; Chi-Jen Tsai; Chin-Yuan Tzen; Yen-Chih Wang; Ching-Yuang Lin; Mai-Szu Wu
Journal:  Nephrol Dial Transplant       Date:  2010-09-29       Impact factor: 5.992

10.  Effect of 5/6 nephrectomized rat serum on epithelial-to-mesenchymal transition in vitro.

Authors:  Zhaoyu Lu; Yuansheng Xie; Xusheng Liu; Shaoyuan Cui; Yuchi Wu; Cun Cai; Lei Zhang; Xiangmei Chen
Journal:  Ren Fail       Date:  2011       Impact factor: 2.606

View more
  11 in total

1.  Efficacy and Safety of Chinese Herbal Formula Granules in Treating Chronic Kidney Disease Stage 3: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial.

Authors:  Jing Zhao; Wei Sun; Jihong Chen; Zhuxing Sun; Dai Chen; Chunhua Cao; Min Yang; Jipei Ma; Ling Wang; Changying Xing; Yan Chen; Meixiao Sheng; Enchao Zhou; Lingdong Xu; Kun Gao; Lihua Liu; Qiong Liu; Lan Yi; Weiming He; Yuanyuan Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-21       Impact factor: 2.629

2.  Understanding and Therapeutic Strategies of Chinese Medicine on Gut-Derived Uremic Toxins in Chronic Kidney Disease.

Authors:  Chuan Guo; Xiang-Rong Rao
Journal:  Chin J Integr Med       Date:  2018-05-11       Impact factor: 1.978

Review 3.  Efficacy and safety of Flos Abelmoschus manihot (Malvaceae) on type 2 diabetic nephropathy: A systematic review.

Authors:  Yi-Zhi Chen; Zhi-Xiang Gong; Guang-Yan Cai; Qing Gao; Xiang-Mei Chen; Li Tang; Ri-Bao Wei; Jian-Hui Zhou
Journal:  Chin J Integr Med       Date:  2014-12-09       Impact factor: 1.978

4.  A system biology approach to understanding the molecular mechanisms of Gubentongluo decoction acting on IgA Nephropathy.

Authors:  Peicheng Shen; Jiaojiao Shen; Chuan Sun; Xuejun Yang; Liqun He
Journal:  BMC Complement Altern Med       Date:  2016-08-24       Impact factor: 3.659

5.  Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis.

Authors:  Xujiao Chen; Shouhong Gao; Mengna Ruan; Sixiu Chen; Jing Xu; Xiaohong Xing; Xiaohong Pan; Changlin Mei; Zhiguo Mao
Journal:  Biosci Rep       Date:  2018-09-13       Impact factor: 3.840

6.  Nanoparticle-Mediated Delivery of Emodin via Colonic Irrigation Attenuates Renal Injury in 5/6 Nephrectomized Rats.

Authors:  Zhaoyu Lu; Chunlan Ji; Xuewen Luo; Yong Lan; Lijuan Han; Yang Chen; Xusheng Liu; Qinzhan Lin; Fuhua Lu; Xiuqing Wu; Rui Guo; Chuan Zou
Journal:  Front Pharmacol       Date:  2021-01-21       Impact factor: 5.810

7.  Rhubarb Enema Increasing Short-Chain Fatty Acids that Improves the Intestinal Barrier Disruption in CKD May Be Related to the Regulation of Gut Dysbiosis.

Authors:  Chunlan Ji; Fuhua Lu; Yuchi Wu; Zhaoyu Lu; Yenan Mo; Lijuan Han; Qizhan Lin; Xusheng Liu; Chuan Zou
Journal:  Biomed Res Int       Date:  2022-01-20       Impact factor: 3.411

8.  Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats.

Authors:  Chunlan Ji; Yin Li; Yenan Mo; Zhaoyu Lu; Fuhua Lu; Qizhan Lin; Xusheng Liu; Chuan Zou; Yuchi Wu
Journal:  Front Pharmacol       Date:  2021-12-13       Impact factor: 5.810

9.  Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.

Authors:  Yu-Qun Zeng; Zhenhua Dai; Fuhua Lu; Zhaoyu Lu; Xusheng Liu; Cha Chen; Pinghua Qu; Dingcheng Li; Zhengshuang Hua; Yanni Qu; Chuan Zou
Journal:  Oncotarget       Date:  2016-04-05

10.  Efficacy and safety of traditional Chinese medicinal enemas for treatment of chronic renal failure: A protocol for systematic review and meta-analysis.

Authors:  Lihua Wu; Yating Wang; Yu Liu; Ling Wu; Dan Cheng; Ting Jiang; Bo Qu; Hongmei Lu; Ju Yang; Anqi Tang; Mingquan Li
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.